Get the latest Science News and Discoveries

FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal


After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot

None

Get the Android app

Or read this on Scientific American

Read more on:

Photo of FDA

FDA

Photo of Moderna

Moderna

Photo of dramatic reversal

dramatic reversal

Related news:

News photo

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

News photo

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

News photo

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise